This graphic shows how you or your loved one can have the best intentions, even get tested and be negative and still infect people at Thanksgiving. This year, love is space. #COVID19

One thing I’ve learned as an oncologist is that a lot of ppl are shocked to find out they’re going to die, much younger than they expected, not how they pictured, & sometimes with little warning. Seeing all these pics of packed airports during #COVID19 reminded me of this 👇

On this Thanksgiving Eve, I am sharing a deeply personal experience in hopes that it will change some behavior before the upcoming holidays. My father died of #COVID in April during the height of the last peak. 1/

START is pleased to announce its newest site, START Mountain Region in Salt Lake City, Utah! This extends the reach of START as one of the largest Phase I cancer research organizations. "We are proud to continue as leaders in this field” said Amita Patnaik #TheCureSTARTsHere

World Schools Debate has exploded here in Texas so it's time to recognize our students at the state level! The Texas Forensic Association is proud to announce the inaugural Team Texas - talented WS students will be competing together across the state.

We are fooling ourselves thinking banning people will prevent omicron from getting here- these countries are just sequencing and finding it. Bravo. It's here. Proper response is to vac up, wear a mask, and we need to surveillance test more.

Very excited to see #XL092 moving forward into multiple histologies, both as mono & CPI. Glad to be a part of this terrific group of investigators including Neeraj Agarwal, MD, FASCO Vivek Subbiah, MD Amita Patnaik #ManishSharma Kristopher Wentzel et al. Please stop by our poster at ASCO #GU22!

Anish Beeram '23 placed 8th nationally at the NSDA Speech and Debate Tournament in the category of Congressional Debate-Senate and also won the Tournament of Champions at the University of Kentucky, making him one of the best Congressional Debaters in the nation. #TMIepiscopal

I am a mother to three little girls, and I am also a Republican. Yesterday’s Supreme Court decision will force millions of little girls to grow up in a world where they lack full bodily autonomy. This isn’t about politics. We must codify Roe v. Wade.

Congratulations to the new members of the 2022-23 USA Debate Team and Development Team! We can’t wait to cheer on these talented debaters 🇺🇸

Earlier this week TMI welcomed KSAT reporter Tiffany Huertas to campus to conducted an interview with Anish Beeram '23 his selection for the USA National Debate Team. Stay tuned to KSAT 12 next week to see Anish! #TMIepiscopal

Congratulations, Anish! I can't wait to see San Antonio represented on the USA National Debate Team. 💪 ksat.com/news/local/202…

Happy #Diwali to our friends and neighbors who celebrate. 🕯️ May light continue to prevail and bring you joy and prosperity. Celebrate Diwali with San Antonio on Nov. 5! anujasa.com/diwali-sa

START is proud to have dosed the first patient in the MOMA-313 Phase 1 trial, a novel therapy targeting polymerase theta for homologous recombination-deficient cancers. Grateful for our partnership with MOMA Therapeutics and the potential impact on patients!

Excellent and timely piece Cristiane D Bergerot, Mazie Tsang, MD, MAS, MS, and Ramy Sedhom, MD, FASCO. ✅ 💻Telehealth has been critical to many of my older adult patients and those living in rural parts of the state. Unfortunately, the flexible provisions associated with telehealth given after the pandemic

On demand! Catch our panel session on #ADC in the future of oncology clinical research: startresearch.wistia.com/medias/94oi2s0…

So grateful to work alongside my exceptional team at START and humbled by this honor. pharmavoice.com/news/pv100-pha…

Exciting news! START’s Dr. Amita Patnaik joins Dr. Shikha Jain MD, FACP on the #OncologyOverdrive podcast. She shares her unique journey in oncology, the critical role of early-phase trials, and START's mission to bring novel treatments to patients. Listen now! tinyurl.com/mpb5sda4

So grateful to Shikha Jain MD, FACP for the opportunity to speak about advocacy for phase I trials!

START Doses 1st US Patient in Moderna's Pan-Tumor Antigen Therapy Study in Solid Tumors Moderna Amita Patnaik oncodaily.com/insight/modern… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #mRNA #mRNA4106 #SolidTumors #START